UNSPSC 41181546: Lipoprotein x immunological test system

In this classification, a Lipoprotein x immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Lipoprotein x. US FDA regulates Lipoprotein x immunological test system under 21 CFR 866.5590 and under FDA product code DEL.

UNSPSC 41181546 Lipoprotein x immunological test system (Commodity) covers specialized analytical laboratory equipment and services for immunological testing, but the recent state and local opportunities posted under this code show minimal direct activity in this narrow product category and instead reflect a diverse set of unrelated laboratory and testing equipment procurements that do not align with the code's nominal scope.

The opportunities identified do not support a coherent framing of what state and local governments are buying under this code. The recent postings include optical surface profilometers (Valencia College, October 2026), airfield photometric testing services (Lee County Port Authority, October and August 2026), software licenses for drug discovery (Jackson State University, October and September 2026), three-phase electrical meter test boards (City of Ocala, September 2026), high-voltage capacitance measurement modules (Kissimmee Utility Authority, September 2026), process instrumentation equipment (Collier County, September 2026), water quality analyzer parts and repair (City of Tampa, August 2026), laboratory equipment maintenance (Texas HHSC/DSHS, August and June 2026), atmospheric monitoring instruments (City of Phoenix, August 2026), nanoindentation systems (Texas State University, August 2026), spectrophotometers (City of Tampa, June 2026), insulating oil testing services (Lubbock Power & Light, June 2026), and brake testing equipment (Colorado State Patrol, July 2026). These solicitations span equipment categories including optics, electrical systems, software, atmospheric monitoring, and mechanical testing—none of which correspond to immunological testing systems or lipoprotein analysis. The geographic distribution includes Florida, Texas, Colorado, Oregon, Arizona, and Ohio, but this reflects the diversity of the unrelated opportunities rather than concentrated activity in a particular market.